Literature DB >> 10079191

Neuronal differentiation of neuro 2a cells by inhibitors of cell cycle progression, trichostatin A and butyrolactone I.

J Inokoshi1, M Katagiri, S Arima, H Tanaka, M Hayashi, Y B Kim, R Furumai, M Yoshida, S Horinouchi, S Omura.   

Abstract

Trichostatin A (TSA, 17 nM), a specific and reversible inhibitor of histone deacetylase induced neurite network formation at and after 4 days. The networks were preserved for at least 3 weeks in the presence of TSA. Butyrolactone I (BLI, 23.6 microM), an inhibitor of cdc2 and cdk2 kinases, also induced neurite extension. Both compounds enhanced the acetylcholinesterase activity of the cells. Cell cycle progression of the cells was blocked by TSA (17 nM) at G1 phase alone. Furthermore, the level of histone hyperacetylation and p21(WAF1) expression in TSA-treated cells increased transiently. These findings suggest that the induction of the neuronal differentiation in Neuro 2a cells by these agents requires the cell cycle arrest at G1 phase, which is caused by inhibition of cycline dependent kinase, a target molecule of BLI and p21(WAF1). Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10079191     DOI: 10.1006/bbrc.1999.0316

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  Activated microglia decrease histone acetylation and Nrf2-inducible anti-oxidant defence in astrocytes: restoring effects of inhibitors of HDACs, p38 MAPK and GSK3β.

Authors:  Fernando Correa; Carina Mallard; Michael Nilsson; Mats Sandberg
Journal:  Neurobiol Dis       Date:  2011-07-02       Impact factor: 5.996

2.  Histone acetylation and its role in embryonic stem cell differentiation.

Authors:  Naiara Z Saraiva; Clara S Oliveira; Joaquim M Garcia
Journal:  World J Stem Cells       Date:  2010-12-26       Impact factor: 5.326

3.  Trichostatin A preferentially reverses the upregulation of gene-expression levels induced by gain of chromosome 7 in colorectal cancer cell lines.

Authors:  Floryne O Buishand; Eric Cardin; Yue Hu; Thomas Ried
Journal:  Genes Chromosomes Cancer       Date:  2017-10-30       Impact factor: 5.006

4.  Mechanisms of action of the novel sulfonamide anticancer agent E7070 on cell cycle progression in human non-small cell lung cancer cells.

Authors:  K Fukuoka; J Usuda; Y Iwamoto; H Fukumoto; T Nakamura; T Yoneda; N Narita; N Saijo; K Nishio
Journal:  Invest New Drugs       Date:  2001       Impact factor: 3.850

5.  Forskolin, an inducer of cAMP, up-regulates acetylcholinesterase expression and protects against organophosphate exposure in neuro 2A cells.

Authors:  Bryan F Curtin; Nabaneeta Pal; Richard K Gordon; Madhusoodana P Nambiar
Journal:  Mol Cell Biochem       Date:  2006-08-19       Impact factor: 3.396

6.  Histone deacetylase inhibition-mediated differentiation of RGC-5 cells and interaction with survival.

Authors:  Brandon R Schwechter; Lucia E Millet; Leonard A Levin
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-06       Impact factor: 4.799

7.  Hippocampal Acetylation may Improve Prenatal-Stress-Induced Depression-Like Behavior of Male Offspring Rats Through Regulating AMPARs Expression.

Authors:  Yong Lu; Junli Zhang; Lin Zhang; Shaokang Dang; Qian Su; Huiping Zhang; Tianwei Lin; Xiaoxiao Zhang; Yurong Zhang; Hongli Sun; Zhongliang Zhu; Hui Li
Journal:  Neurochem Res       Date:  2017-10-10       Impact factor: 3.996

8.  Control of cytomegalovirus lytic gene expression by histone acetylation.

Authors:  Jane C Murphy; Wolfgang Fischle; Eric Verdin; John H Sinclair
Journal:  EMBO J       Date:  2002-03-01       Impact factor: 11.598

9.  Butyrolactone-I from Coral-Derived Fungus Aspergillus terreus Attenuates Neuro-Inflammatory Response via Suppression of NF-κB Pathway in BV-2 Cells.

Authors:  Yuan Yuan Zhang; Yi Zhang; Yuan-Bei Yao; Xiao-Ling Lei; Zhong-Ji Qian
Journal:  Mar Drugs       Date:  2018-06-07       Impact factor: 5.118

Review 10.  Epigenetic mechanisms during ageing and neurogenesis as novel therapeutic avenues in human brain disorders.

Authors:  Raúl Delgado-Morales; Roberto Carlos Agís-Balboa; Manel Esteller; María Berdasco
Journal:  Clin Epigenetics       Date:  2017-06-29       Impact factor: 6.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.